Iovance Biotherapeutics Stock Price History
| IOVA Stock | USD 3.54 0.02 0.56% |
Below is the normalized historical share price chart for Iovance Biotherapeutics extending back to October 15, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Iovance Biotherapeutics stands at 3.54, as last reported on the 22nd of March, with the highest price reaching 3.58 and the lowest price hitting 3.42 during the day.
If you're considering investing in Iovance Stock, it is important to understand the factors that can impact its price. Iovance Biotherapeutics holds Efficiency (Sharpe) Ratio of -0.27, which attests that the entity had a -0.27 % return per unit of risk over the last 3 months. Iovance Biotherapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Iovance Biotherapeutics' Standard Deviation of 4.15, market risk adjusted performance of (1.80), and Risk Adjusted Performance of (0.23) to validate the risk estimate we provide.
At present, Iovance Biotherapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 304.4 M, whereas Common Stock Total Equity is forecasted to decline to 4,118. . As of March 22, 2025, Price To Sales Ratio is expected to decline to 12.42. In addition to that, Price Earnings Ratio is expected to decline to -6.05. Iovance Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of October 2010 | 200 Day MA 8.1746 | 50 Day MA 5.1608 | Beta 0.929 |
Iovance |
Sharpe Ratio = -0.2663
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IOVA |
Estimated Market Risk
| 4.21 actual daily | 37 63% of assets are more volatile |
Expected Return
| -1.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.27 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Iovance Biotherapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Iovance Biotherapeutics by adding Iovance Biotherapeutics to a well-diversified portfolio.
Price Book 1.6315 | Enterprise Value Ebitda (8.68) | Price Sales 7.0843 | Shares Float 251.9 M | Wall Street Target Price 19.5385 |
Iovance Biotherapeutics Stock Price History Chart
There are several ways to analyze Iovance Stock price data. The simplest method is using a basic Iovance candlestick price chart, which shows Iovance Biotherapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 2, 2025 | 7.79 |
| Lowest Price | March 13, 2025 | 3.52 |
Iovance Biotherapeutics March 22, 2025 Stock Price Synopsis
Various analyses of Iovance Biotherapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Iovance Stock. It can be used to describe the percentage change in the price of Iovance Biotherapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Iovance Stock.| Iovance Biotherapeutics Price Action Indicator | 0.03 | |
| Iovance Biotherapeutics Price Daily Balance Of Power | (0.12) | |
| Iovance Biotherapeutics Price Rate Of Daily Change | 0.99 |
Iovance Biotherapeutics March 22, 2025 Stock Price Analysis
Iovance Stock Price History Data
The price series of Iovance Biotherapeutics for the period between Sun, Dec 22, 2024 and Sat, Mar 22, 2025 has a statistical range of 4.32 with a coefficient of variation of 23.64. Under current investment horizon, the daily prices are spread out with arithmetic mean of 5.73. The median price for the last 90 days is 5.81. The company completed 1:100 stock split on 26th of September 2013.| Open | High | Low | Close | Volume | ||
03/22/2025 | 3.48 | 3.58 | 3.42 | 3.54 | ||
| 03/21/2025 | 3.48 | 3.58 | 3.42 | 3.54 | 7,550,900 | |
| 03/20/2025 | 3.54 | 3.71 | 3.52 | 3.54 | 6,135,028 | |
| 03/19/2025 | 3.57 | 3.66 | 3.52 | 3.56 | 10,121,176 | |
| 03/18/2025 | 3.71 | 3.74 | 3.55 | 3.57 | 6,203,896 | |
| 03/17/2025 | 3.62 | 3.84 | 3.61 | 3.74 | 9,229,820 | |
| 03/14/2025 | 3.54 | 3.62 | 3.48 | 3.59 | 8,189,466 | |
| 03/13/2025 | 3.82 | 3.92 | 3.50 | 3.52 | 10,354,469 | |
| 03/12/2025 | 3.91 | 4.01 | 3.73 | 3.82 | 7,655,936 | |
| 03/11/2025 | 3.75 | 3.97 | 3.71 | 3.90 | 7,610,620 | |
| 03/10/2025 | 3.68 | 3.76 | 3.61 | 3.73 | 8,182,852 | |
| 03/07/2025 | 3.70 | 3.80 | 3.58 | 3.75 | 9,982,167 | |
| 03/06/2025 | 3.88 | 3.95 | 3.74 | 3.75 | 9,813,568 | |
| 03/05/2025 | 4.02 | 4.19 | 3.88 | 4.05 | 11,211,793 | |
| 03/04/2025 | 3.92 | 3.96 | 3.75 | 3.92 | 18,351,517 | |
| 03/03/2025 | 4.27 | 4.57 | 3.99 | 4.04 | 18,677,142 | |
| 02/28/2025 | 3.92 | 4.43 | 3.62 | 4.24 | 49,310,916 | |
| 02/27/2025 | 5.36 | 5.64 | 5.25 | 5.26 | 12,305,223 | |
| 02/26/2025 | 5.39 | 5.52 | 5.31 | 5.35 | 6,865,146 | |
| 02/25/2025 | 5.53 | 5.59 | 5.23 | 5.34 | 7,837,378 | |
| 02/24/2025 | 5.71 | 5.88 | 5.47 | 5.55 | 8,373,476 | |
| 02/21/2025 | 5.69 | 6.09 | 5.68 | 5.78 | 10,818,757 | |
| 02/20/2025 | 5.64 | 5.67 | 5.45 | 5.61 | 7,021,100 | |
| 02/19/2025 | 5.50 | 5.73 | 5.44 | 5.65 | 6,538,304 | |
| 02/18/2025 | 5.66 | 5.80 | 5.54 | 5.56 | 5,538,296 | |
| 02/14/2025 | 5.40 | 5.75 | 5.40 | 5.57 | 8,118,413 | |
| 02/13/2025 | 5.41 | 5.42 | 5.06 | 5.34 | 7,661,797 | |
| 02/12/2025 | 5.21 | 5.42 | 5.20 | 5.34 | 5,529,875 | |
| 02/11/2025 | 5.24 | 5.34 | 5.05 | 5.29 | 9,442,160 | |
| 02/10/2025 | 5.77 | 5.78 | 5.30 | 5.32 | 10,990,329 | |
| 02/07/2025 | 5.85 | 5.93 | 5.63 | 5.69 | 5,623,041 | |
| 02/06/2025 | 6.13 | 6.16 | 5.85 | 5.88 | 5,395,067 | |
| 02/05/2025 | 5.84 | 6.10 | 5.84 | 6.10 | 6,106,280 | |
| 02/04/2025 | 5.63 | 5.83 | 5.57 | 5.81 | 5,390,300 | |
| 02/03/2025 | 5.59 | 5.99 | 5.52 | 5.64 | 9,255,600 | |
| 01/31/2025 | 6.12 | 6.15 | 5.81 | 5.85 | 9,082,100 | |
| 01/30/2025 | 6.16 | 6.36 | 6.15 | 6.21 | 6,442,900 | |
| 01/29/2025 | 6.12 | 6.23 | 5.90 | 6.07 | 9,256,800 | |
| 01/28/2025 | 6.28 | 6.30 | 6.07 | 6.19 | 5,746,400 | |
| 01/27/2025 | 6.18 | 6.50 | 6.11 | 6.25 | 8,089,000 | |
| 01/24/2025 | 6.24 | 6.38 | 5.99 | 6.25 | 6,010,600 | |
| 01/23/2025 | 5.90 | 6.21 | 5.70 | 6.19 | 7,887,400 | |
| 01/22/2025 | 5.90 | 6.05 | 5.80 | 5.99 | 8,381,600 | |
| 01/21/2025 | 5.99 | 6.06 | 5.57 | 5.88 | 11,462,900 | |
| 01/17/2025 | 5.90 | 6.00 | 5.79 | 5.91 | 6,557,900 | |
| 01/16/2025 | 5.93 | 5.99 | 5.62 | 5.76 | 9,464,600 | |
| 01/15/2025 | 6.18 | 6.28 | 5.84 | 5.91 | 9,106,100 | |
| 01/14/2025 | 5.94 | 6.44 | 5.87 | 5.89 | 15,616,100 | |
| 01/13/2025 | 6.31 | 6.35 | 5.77 | 5.78 | 16,808,700 | |
| 01/10/2025 | 7.00 | 7.03 | 6.24 | 6.40 | 18,544,500 | |
| 01/08/2025 | 7.30 | 7.34 | 7.00 | 7.17 | 7,951,900 | |
| 01/07/2025 | 7.50 | 7.69 | 7.25 | 7.40 | 7,909,500 | |
| 01/06/2025 | 7.71 | 7.78 | 7.41 | 7.48 | 5,879,400 | |
| 01/03/2025 | 7.83 | 7.97 | 7.57 | 7.65 | 7,587,000 | |
| 01/02/2025 | 7.54 | 8.15 | 7.40 | 7.79 | 7,466,600 | |
| 12/31/2024 | 7.27 | 7.45 | 7.12 | 7.40 | 7,594,100 | |
| 12/30/2024 | 7.24 | 7.34 | 7.05 | 7.17 | 9,751,600 | |
| 12/27/2024 | 7.55 | 7.62 | 7.21 | 7.37 | 7,358,000 | |
| 12/26/2024 | 7.40 | 7.63 | 7.27 | 7.60 | 6,161,600 | |
| 12/24/2024 | 7.45 | 7.50 | 7.24 | 7.49 | 3,542,900 | |
| 12/23/2024 | 7.38 | 7.66 | 7.36 | 7.46 | 7,347,200 |
About Iovance Biotherapeutics Stock history
Iovance Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Iovance is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Iovance Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Iovance Biotherapeutics stock prices may prove useful in developing a viable investing in Iovance Biotherapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 289.9 M | 304.4 M | |
| Net Loss | -356.3 M | -338.5 M |
Iovance Biotherapeutics Quarterly Net Working Capital |
|
Iovance Biotherapeutics Stock Technical Analysis
Iovance Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Iovance Biotherapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Iovance Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Iovance Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Iovance to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.23) | |||
| Jensen Alpha | (1.07) | |||
| Total Risk Alpha | (0.80) | |||
| Treynor Ratio | (1.81) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Iovance Stock analysis
When running Iovance Biotherapeutics' price analysis, check to measure Iovance Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iovance Biotherapeutics is operating at the current time. Most of Iovance Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Iovance Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iovance Biotherapeutics' price. Additionally, you may evaluate how the addition of Iovance Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |